The Bioprocessing Summit, taking place August 10–13, 2026, in Boston, is the industry’s flagship event for advancing bioprocessing science, technology and manufacturing. Bringing together scientists, engineers and CMC leaders from across the biopharmaceutical industry, the Summit explores the latest innovations driving the development of increasingly complex therapeutics. The expanded 2026 programme features emerging modalities including ADCs, oligonucleotides and peptides; applied AI and digitalisation strategies; novel expression systems; and next-generation analytical approaches. From process development and manufacturing to quality and scale-up, attendees gain practical insights, actionable solutions and valuable connections to help shape the future of biomanufacturing. Learn more at https://www.BioprocessingSummit.com